GGrantIndex
Sort

40,608 grants matching prostate cancer

TARGETED, ON-DEMAND CHARGE CONVERSIONAL NANOTHERAPEUTICS FOR ADVANCED PROSTATE CANCER

$333,104
University Of Utah · · FY2013 · Department of the Army

Control of T Lymphopoiesis and Growth by Mad Genes

$333,085
Brian M Iritani · University Of Washington · R01 · FY2006 · AI

CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer

$333,082
Scott D Cramer · University Of Colorado Denver · R01 · FY2018 · CA

Chemical Gating of a Tube-in-a-Tube Semiconductor

$333,042
Yuhuang Wang · Univ Of Maryland, College Park · R01 · FY2015 · GM

Project 3

$333,018
Anindya Dutta · University Of Virginia · P01 · FY2015 · CA

PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN

$333,010
Theresa A Guise · University Of Virginia · R01 · FY2008 · DK

SYSTEMATIC SEARCH FOR GENE-GENE INTERACTION EFFECT ON PROSTATE CANCER RISK

$333,000
Wake Forest University Health Sciences · · FY2009 · Department of the Army

THE ROLE OF TKS5 SIGNALING IN PROSTATE CANCER CELL INVASION AND METASTASIS

$333,000
Wake Forest University Health Sciences · · FY2008 · Department of the Army

MICROENVIRONMENT-SENSITIVE MULITIMODAL CONTRAST AGENT FOR PROSTATE CANCER DIAGNOSIS

$333,000
Auburn University · · FY2013 · Department of Defense

Multimodality Molecular Nanoimaging of Cancer

$332,933
Sanjiv S Gambhir · Stanford University · U54 · FY2017 · CA

Prostate Cancer Prevention and Treatment by Silibinin

$332,920
Rajesh Agarwal · University Of Colorado Denver · R01 · FY2010 · CA

The Interplay Between Sleep, Melatonin, and Mortality in Older Men

$332,901
Eva S Schernhammer · Brigham And Women'S Hospital · R01 · FY2008 · AG

Mitigating Cancer Treatment-Related Fatigue by Exercise

$332,897
Johns Hopkins University · R01 · FY2004 · NR

Project 1: Resistance caused by AR pathway reactivation

$332,817
Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA

AUTOMATIC IMAGE REGISTRATION FOR PROSTATE RADIOTHERAPY

$332,771
Yale University · R01 · FY2000 · CA

CANCER AND LEUKEMIA GROUP B

$332,763
Dana-Farber Cancer Institute · U10 · FY2000 · CA

A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER

$332,667
Baylor College Of Medicine · R01 · FY2003 · ES

Vitamin D and Dexamethasone in Myelodysplastic Syndromes

$332,638
University Of Pittsburgh At Pittsburgh · R21 · FY2002 · CA

Epigenetic Regulated Genes in African-American Prostate Cancer Patients

$332,585
Bernard Kwabi-Addo · Howard University · U54 · FY2023 · MD

CHOLESTEROL SYNTHESIS AND STATIN THERAPY IN PROSTATE CANCER

$332,585
Sloan-Kettering Institute For Cancer Research · · FY2018 · Department of the Army

Treatment of Castration-resistant Prostate Cancer (CRPC)

$332,580
Xiaoqi Liu · University Of Kentucky · R01 · FY2019 · CA

Studies of Non-Ionizing Radiation-Related Cancer

$332,568
Peter D Inskip · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

Prostate Cancer Prevention by Procyanidins in Grape Seed Extract

$332,558
Chapla Agarwal · University Of Colorado Denver · R01 · FY2010 · CA

THE AIF/XIAP AXIS IN PROSTATE CANCER

$332,556
Wake Forest University Health Sciences · · FY2008 · Department of the Army

Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma

$332,550
Dai H Chung · Vanderbilt University · R01 · FY2012 · DK